| Generic | |
| BV | Bee Venom |
| DW | Dry Weight |
| RA | Rheumatoid Arthritis |
| PD | Parkinson’s Disease |
| MS | Multiple Sclerosis |
| LF | Liver Fibrosis |
| CNS | Central Nervous System |
| AD | Alzheimer’s Disease |
| Components | |
| Aa | Amino acid |
| PLA2 | Phospholipase A2 |
| MCD | Mast Cell-Degranulating Peptide |
| NO | Nitric Oxide |
| bPLA2 | PLA2 Derived From Bee |
| MDA | Malondialdehyde |
| ASA | Acetylsalicylic Acid |
| LPS | Lipopolysaccharides |
| DPIV | Dipeptidyl Peptidase IV |
| GST | Glutathione S-Transferase |
| GSH | Glutathione Content |
| GPx | Glutathione Peroxidase |
| SOD | Superoxide Dismutase |
| Kir | Inward Rectifier Potassium |
| Cellular components | |
| TLR | Toll-Like Receptors |
| DR | Death Receptor |
| CD | Cluster of Differentiation |
| TNF | Tumor Necrosis Factors |
| TAM | Tumor-Associated Macrophages |
| IL | Interleukin |
| NF-kB | Inhibitory effect of the nuclear factor kappa-B |
| Antioxidant activity | |
| TBARS | Thiobarbituric Acid Reactive Substances |
| TAS | Plasma Total Antioxidant Status |
| TOS | Total Oxidant Status |
| OSI | Oxidative Stress Index |
| FRAP | Ferric Reducing/Antioxidant Power |
| ABTS | 2, 20-Azinobis 3-Ethylbenzothiazoline-6-Sulfonic Acid |
| TAC | Total Antioxidant Capacity |